ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: TH-PO227

Exploring the Spectrum of Blood Pressure Associations with CKD: The International 24-Hour Aortic Blood Pressure Consortium (i24ABC)

Session Information

Category: Hypertension and CVD

  • 1602 Hypertension and CVD: Clinical

Authors

  • Aoun Bahous, Sola, Lebanese American University School of Medicine, Byblos, Lebanon
  • Weber, Thomas, Klinikum Wels-Grieskirchen GmbH, Wels, Oberösterreich, Austria
  • Haddad, Chadia Souheil, Lebanese American University School of Medicine, Byblos, Lebanon
  • Salameh, Pascale, Lebanese American University School of Medicine, Byblos, Lebanon
  • De La Sierra, Alejandro, Universitat de Barcelona Facultat de Medicina i Ciencies de la Salut, Barcelona, Catalunya, Spain
  • Argyris, Antonios A., Ethniko kai Kapodistriako Panepistemio Athenon Iatrike Schole, Athens, Attica, Greece
  • Hametner, Bernhard, Austrian Institute of Technology GmbH, Wien, Wien, Austria
  • Mayer, Christopher C., Austrian Institute of Technology GmbH, Wien, Wien, Austria
  • Piskorz, Daniel Leonardo, Instituto de Cardiologia Sanatorio Britanico SA, Santa Fe, Argentina
  • Terentes-Printzios, Dimitrios, Ethniko kai Kapodistriako Panepistemio Athenon, Athens, Attica, Greece
  • Rodilla, Enrique, Universidad Cardenal Herrera-CEU, Valencia, Spain
  • Gkaliagkousi, Eugenia, Aristoteleio Panepistemio Thessalonikes Schole Epistemon Ygeias, Thessaloniki, Central Macedonia, Greece
  • Pierce, Gary L., The University of Iowa, Iowa City, Iowa, United States
  • Stergiou, George, Ethniko kai Kapodistriako Panepistemio Athenon, Athens, Attica, Greece
  • Pucci, Giacomo, Universita degli Studi di Perugia, Perugia, Umbria, Italy
  • Blacher, Jacques, Hopital Hotel-Dieu de Paris, Paris, Île-de-France, France
  • Kario, Kazuomi, Jichi Ika Daigaku, Shimotsuke, Tochigi, Japan
  • Muiesan, Maria Lorenza, Universita degli Studi di Brescia, Brescia, Lombardia, Italy
  • Agharazii, Mohsen, Universite Laval, Quebec, Quebec, Canada
  • Jankowski, Piotr, Uniwersytet Jagiellonski w Krakowie Collegium Medicum, Krakow, Małopolskie, Poland
  • Perl, Sabine, Medizinische Universitat Graz, Graz, Steiermark, Austria
  • Wassertheurer, Siegfried, Austrian Institute of Technology GmbH, Wien, Wien, Austria
  • Zhang, Yi, Shanghai Tenth People's Hospital, Shanghai, China
  • Orter, Stefan, Austrian Institute of Technology GmbH, Wien, Wien, Austria
  • Protogerou, Athanase, Ethniko kai Kapodistriako Panepistemio Athenon Iatrike Schole, Athens, Attica, Greece

Group or Team Name

  • The International 24-Hour Aortic Blood Pressure Consortium (i24ABC).
Background

Chronic kidney disease (CKD) has emerged as a significant public health concern. The kidneys are primarily exposed to pulsatile rather than steady hemodynamics, which complicates the bidirectional relationship between CKD and hypertension. We aimed to explore relationships between blood pressure (BP) parameters and renal function in a pooled dataset from 21 centers worldwide.

Methods

The dataset included clinical and hemodynamic information. All participants underwent office BP measurements, in addition to 24-hour ambulatory BP monitoring (ABPM) with the same validated automated brachial oscillometric device (Mobil-O-Graph, I.E.M., Germany) using a transfer function for central pressure, and mean/diastolic pressure calibration. Renal function was estimated using the CKD-EPI equation and subjects classified into the 6 eGFR categories following the KDIGO 2021 guideline.

Results

We included 5204 subjects, 46.1% females, with a mean age of 60.8 ± 13.9 years. Diabetes was noted in 14.7% and hypertension in 70.3% of subjects, 76% of whom were on antihypertensive therapy. The mean eGFR was 88.5 ± 19.9 mL/min/1.73 m2. More than half of the participants (56.5%) had a normal or high eGFR (G1) and only 1.9% had a severely decreased eGFR (G5). The prevalence of hypertension increased progressively across GFR categories with 95.7% of subjects in G5 vs. 67.7% in G1 (p<0.001) with hypertension. Diastolic BP tended to decrease (p<0.001) and SBP to increase (p<0.001) with decreasing eGFR. These associations were consistent for both brachial and central values, and for office and ABPM measurement techniques. Systolic reverse dipping status was independently associated with decreased eGFR after adjustment for gender and age, and irrespective of hypertension status (β=-1.74, p=0.004).

Conclusion

CKD is associated with adverse hemodynamic changes, both at the brachial and the aortic level, and in office and out-of-office measurements, indicative of arterial stiffening.